Rockland, Massachusetts – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list.
EMD Serono submitted a joint nomination with MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany as the Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany. Based on employee survey results, both were named to the list of “Top Places to Work.”
“The fact that we achieved this recognition based on the positive input of our employees is extremely meaningful, as we are always exploring ways to ensure our company is one where everyone can do their best work each and every day,” said Gary Zieziula, President and Managing Director, EMD Serono. “Our employees are going above and beyond to achieve our collective mission of accelerating innovation for difficult to treat diseases.”
The Boston Globe’s research partner, Workplace Dynamics, ranked 125 Massachusetts employers by analysing employee responses to a confidential 24-question survey. The survey covered several topics including benefits, management and employee engagement.
About EMD Serono, Inc.
EMD Serono is the biopharma business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology as R&D focus areas. Today, the business has 1,200 employees around the country with commercial, clinical and research operations based in the company’s home state of Massachusetts. www.emdserono.com
SOURCE EMD Serono